Clinical Trials Browser

Phase 2 × GC1118 × Gastrointestinal × Clear all

NCT04077255 2022-11-30

EGFR-targeted Therapy for Gastric Cancer

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma of the Stomach